RhPDGF-BB promotes proliferation and osteogenic differentiation of bone marrow stromal cells from streptozotocin-induced diabetic rats through ERK pathway

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zhao, Yanfang ^a,b,c   Zhang, Songmei ^a   Zeng, Deliang ^a   Xia, Lunguo ^a   Lamichhane, Ashwini ^a   Jiang, Xinquan ^a   Zhang, Fuqiang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c Shanghai Stomatological Disease Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALKALINE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; TRANSCRIPTION FACTOR RUNX2; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; FLAVONOID; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE MARROW CELL; BONE METABOLISM; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MINERALIZATION; MTT ASSAY; NONHUMAN; OSSIFICATION; OSTEOBLAST; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; STROMA CELL; UPREGULATION; WESTERN BLOTTING; ANIMAL; BONE REGENERATION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; BONE MARROW CELLS; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; HUMANS; MAP KINASE SIGNALING SYSTEM; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-SIS; RATS;

EID: 84896817846     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/637415     Document Type: Article

References (39)

1. Xu Y., Wang L., He J., Bi Y., Li M., Wang T., Wang L., Jiang Y., Dai M., Lu J., Xu M., Li Y., Hu N., Li J., Mi S., Chen C. S., Li G., Mu Y., Zhao J., Kong L., Chen J., Lai S., Wang W., Zhao W., Ning G., Prevalence and control of diabetes in Chinese adults. The Journal of the American Medical Association 2013 310 9 948 959 10.1001/jama.2013.168118
2. Silva M. J., Brodt M. D., Lynch M. A., McKenzie J. A., Tanouye K. M., Nyman J. S., Wang X., Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. Journal of Bone and Mineral Research 2009 24 9 1618 1627 2-s2.0-72749099565 10.1359/jbmr.090316
3. Janghorbani M., van Dam R. M., Willett W. C., Hu F. B., Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. The American Journal of Epidemiology 2007 166 5 495 505 2-s2.0-34548017660 10.1093/aje/kwm106
4. Yaturu S., Diabetes and skeletal health. Journal of Diabetes 2009 1 4 246 254 2-s2.0-79952196973
5. Cozen L., Does diabetes delay fracture healing? Clinical Orthopaedics and Related Research 1972 82 134 140 2-s2.0-0015262830
6. Herskind A. M., Christensen K., Norgaard-Andersen K., Andersen J. F., Diabetes mellitus and healing of closed fractures. Diabete et Metabolisme 1992 18 1 63 64 2-s2.0-0026550170
7. Vestergaard P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporosis International 2007 18 4 427 444 2-s2.0-33847629923 10.1007/s00198-006-0253-4
8. Harada S., Rodan G. A., Control of osteoblast function and regulation of bone mass. Nature 2003 423 6937 349 355 2-s2.0-0037673933 10.1038/nature01660
9. Hofbauer L. C., Brueck C. C., Singh S. K., Dobnig H., Osteoporosis in patients with diabetes mellitus. Journal of Bone and Mineral Research 2007 22 9 1317 1328 2-s2.0-36048980980 10.1359/jbmr.070510
10. McCabe L. R., Understanding the pathology and mechanisms of type I diabetic bone loss. Journal of Cellular Biochemistry 2007 102 6 1343 1357 2-s2.0-36849045166 10.1002/jcb.21573
11. Ogasawara A., Nakajima A., Nakajima F., Goto K., Yamazaki M., Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. Bone 2008 43 5 832 839 2-s2.0-53349162244 10.1016/j.bone.2008.07.246
12. Khosla S., Westendorf J. J., Mödder U. I., Concise review: insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem Cells 2010 28 12 2124 2128 2-s2.0-78651082309 10.1002/stem.546
13. Mauney J. R., Volloch V., Kaplan D. L., Role of adult mesenchymal stem cells in bone tissue-engineering applications: current status and future prospects. Tissue Engineering 2005 11 5-6 787 802 2-s2.0-20444454865 10.1089/ten.2005.11.787
14. Zhao Y. F., Zeng D. L., Xia L. G., Zhang S. M., Xu L. Y., Jiang X. Q., Zhang F. Q., Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats. International Journal of Molecular Medicine 2013 31 3 614 620 10.3892/ijmm.2013.1227
15. Stolzing A., Sellers D., Llewelyn O., Scutt A., Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs 2010 191 6 453 465 2-s2.0-77952954547 10.1159/000281826
16. Hollinger J. O., Hart C. E., Hirsch S. N., Lynch S., Friedlaender G. E., Recombinant human platelet-derived growth factor: biology and clinical applications. Journal of Bone and Joint Surgery A 2008 90 supplement 1 48 54 2-s2.0-40149093562 10.2106/JBJS.G.01231
17. Tyndall W. A., Beam H. A., Zarro C., O'Connor J. P., Lin S. S., Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clinical Orthopaedics and Related Research 2003 408 319 330 2-s2.0-0037337693
18. Nevins M., Giannobile W. V., McGuire M. K., Kao R. T., Mellonig J. T., Hinrichs J. E., McAllister B. S., Murphy K. S., McClain P. K., Nevins M. L., Paquette D. W., Han T. J., Reddy M. S., Lavin P. T., Genco R. J., Lynch S. E., Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. Journal of Periodontology 2005 76 12 2205 2215 2-s2.0-30944432610 10.1902/jop.2005.76.12. 2205
19. Caplan A. I., Correa D., PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. Journal of Orthopaedic Research 2011 29 12 1795 1803 2-s2.0-80955178835 10.1002/jor.21462
20. McCarthy H. S., Williams J. H. H., Davie M. W. J., Marshall M. J., Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. Journal of Cellular Physiology 2009 218 2 350 354 2-s2.0-58149214694 10.1002/jcp.21600
21. Hollinger J. O., Onikepe A. O., MacKrell J., Einhorn T., Bradica G., Lynch S., Hart C. E., Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable β -tricalcium phosphate/collagen matrix. Journal of Orthopaedic Research 2008 26 1 83 90 2-s2.0-38049090640 10.1002/jor.20453
22. Xu L., Lv K., Zhang W., Zhang X., Jiang X., Zhang F., The healing of critical-size calvarial bone defects in rat with rhPDGF-BB, BMSCs, and β -TCP scaffolds. Journal of Materials Science: Materials in Medicine 2012 23 4 1073 1084 2-s2.0-84856487602 10.1007/s10856-012-4558-x
23. Al-Zube L., Breitbart E. A., O'Connor J. P., Parsons J. R., Bradica G., Hart C. E., Lin S. S., Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and β -tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. Journal of Orthopaedic Research 2009 27 8 1074 1081 2-s2.0-67749147120 10.1002/jor.20842
24. Retzepi M., Lewis M. P., Donos N., Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration. Clinical Oral Implants Research 2010 21 1 71 79 2-s2.0-72949085526 10.1111/j.1600-0501. 2009.01805.x
25. Lü K., Zeng D., Zhang Y., Xia L., Xu L., Kaplan D. L., Jiang X., Zhang F., BMP-2 gene modified canine bMSCs promote ectopic bone formation mediated by a nonviral PEI derivative. Annals of Biomedical Engineering 2011 39 6 1829 1839 2-s2.0-79958808874 10.1007/s10439-011-0276-7
26. Jiang X., Zhao J., Wang S., Sun X., Zhang X., Chen J., Kaplan D. L., Zhang Z., Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials 2009 30 27 4522 4532 2-s2.0-67749114142 10.1016/j.biomaterials.2009.05.021
27. Retzepi M., Donos N., The effect of diabetes mellitus on osseous healing. Clinical Oral Implants Research 2010 21 7 673 681 2-s2.0-77954605645 10.1111/j.1600-0501.2010.01923.x
28. Breitbart E. A., Meade S., Azad V., Yeh S., Al-Zube L., Lee Y., Benevenia J., Arinzeh T. L., Lin S. S., Mesenchymal stem cells accelerate bone allograft incorporation in the presence of diabetes mellitus. Journal of Orthopaedic Research 2010 28 7 942 949 2-s2.0-77953193003 10.1002/jor.21065
29. Khan M., Akhtar S., Mohsin S., N. Khan S., Riazuddin S., Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells. Stem Cells and Development 2011 20 1 67 75 2-s2.0-78650973243 10.1089/scd.2009.0397
30. Cramer C., Freisinger E., Jones R. K., Slakey D. P., Dupin C. L., Newsome E. R., Alt E. U., Izadpanah R., Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells and Development 2010 19 12 1875 1884 2-s2.0-78649696999 10.1089/scd.2010.0009
31. Mezawa M., Araki S., Takai H., Sasaki Y., Wang S., Li X., Kim D., Nakayama Y., Ogata Y., Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB. Gene 2009 435 1-2 80 87 2-s2.0-61649091282 10.1016/j.gene.2008.12.020
32. Haque T., Uludag H., Zernicke R. F., Winn S. R., Sebald W., Bone marrow cells from normal and ovariectomized rats respond differently to basic fibroblast growth factor and bone morphogenetic protein 2 treatment in vitro. Tissue Engineering 2005 11 3-4 634 644 2-s2.0-18244372683 10.1089/ten.2005.11. 634
33. Mehrotra M., Krane S. M., Walters K., Pilbeam C., Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. Journal of Cellular Biochemistry 2004 93 4 741 752 2-s2.0-21744459448 10.1002/jcb.20138
34. Franceschi R. T., Ge C., Xiao G., Roca H., Jiang D., Transcriptional regulation of osteoblasts. Annals of the New York Academy of Sciences 2007 1116 196 207 2-s2.0-37249028142 10.1196/annals.1402.081
35. Komori T., Regulation of skeletal development by the Runx family of transcription factors. Journal of Cellular Biochemistry 2005 95 3 445 453 2-s2.0-22644447278 10.1002/jcb.20420
36. Gharibi B., Ghuman M. S., Hughes F. J., Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRbeta-induced MSC self-renewal. Journal of Cellular and Molecular Medicine 2012 16 11 2789 2801 10.1111/j.1582-4934.2012.01602.x
37. Ge C., Xiao G., Jiang D., Franceschi R. T., Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. Journal of Cell Biology 2007 176 5 709 718 2-s2.0-33847375078 10.1083/jcb.200610046
38. Xiao G., Jiang D., Thomas P., Benson M. D., Guan K., Karsenty G., Franceschi R. T., MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. The Journal of Biological Chemistry 2000 275 6 4453 4459 2-s2.0-0034635477 10.1074/jbc.275.6.4453
39. Ge C., Yang Q., Zhao G., Yu H., Kirkwood K. L., Franceschi R. T., Interactions between extracellular signal-regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. Journal of Bone and Mineral Research 2012 27 3 538 551 2-s2.0-84857320794 10.1002/jbmr.561